Correlation Between Aerovate Therapeutics and AN2 Therapeutics
Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and AN2 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and AN2 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aerovate Therapeutics and AN2 Therapeutics, you can compare the effects of market volatilities on Aerovate Therapeutics and AN2 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of AN2 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and AN2 Therapeutics.
Diversification Opportunities for Aerovate Therapeutics and AN2 Therapeutics
0.29 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Aerovate and AN2 is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and AN2 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AN2 Therapeutics and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with AN2 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AN2 Therapeutics has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and AN2 Therapeutics go up and down completely randomly.
Pair Corralation between Aerovate Therapeutics and AN2 Therapeutics
Given the investment horizon of 90 days Aerovate Therapeutics is expected to generate 1.21 times more return on investment than AN2 Therapeutics. However, Aerovate Therapeutics is 1.21 times more volatile than AN2 Therapeutics. It trades about -0.04 of its potential returns per unit of risk. AN2 Therapeutics is currently generating about -0.43 per unit of risk. If you would invest 269.00 in Aerovate Therapeutics on November 2, 2024 and sell it today you would lose (7.00) from holding Aerovate Therapeutics or give up 2.6% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Aerovate Therapeutics vs. AN2 Therapeutics
Performance |
| Timeline |
| Aerovate Therapeutics |
| AN2 Therapeutics |
Aerovate Therapeutics and AN2 Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aerovate Therapeutics and AN2 Therapeutics
The main advantage of trading using opposite Aerovate Therapeutics and AN2 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, AN2 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AN2 Therapeutics will offset losses from the drop in AN2 Therapeutics' long position.| Aerovate Therapeutics vs. Adagene | Aerovate Therapeutics vs. Acrivon Therapeutics, Common | Aerovate Therapeutics vs. Rezolute | Aerovate Therapeutics vs. AN2 Therapeutics |
| AN2 Therapeutics vs. Aerovate Therapeutics | AN2 Therapeutics vs. Adagene | AN2 Therapeutics vs. Acrivon Therapeutics, Common | AN2 Therapeutics vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |